Stephens Consulting’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,000
| Closed | -$6.94K | – | 545 |
|
|
2024
Q3 | $6.94K | Hold |
1,000
| – | – | ﹤0.01% | 367 |
|
|
2024
Q2 | $4.9K | Sell |
1,000
-1,000
| -50% | -$4.9K | ﹤0.01% | 405 |
|
|
2024
Q1 | $11.6K | Hold |
2,000
| – | – | ﹤0.01% | 297 |
|
|
2023
Q4 | $13.1K | Hold |
2,000
| – | – | ﹤0.01% | 285 |
|
|
2023
Q3 | $9.64K | Hold |
2,000
| – | – | ﹤0.01% | 314 |
|
|
2023
Q2 | $10.2K | Hold |
2,000
| – | – | ﹤0.01% | 307 |
|
|
2023
Q1 | $11K | Hold |
2,000
| – | – | 0.01% | 306 |
|
|
2022
Q4 | $9.18K | Hold |
2,000
| – | – | 0.01% | 311 |
|
|
2022
Q3 | $12.5K | Hold |
2,000
| – | – | 0.01% | 295 |
|
|
2022
Q2 | $8.92K | Hold |
2,000
| – | – | 0.01% | 339 |
|
|
2022
Q1 | $10.1K | Sell |
2,000
-225
| -10% | -$1.13K | 0.01% | 348 |
|
|
2021
Q4 | $19.4K | Buy |
+2,225
| New | +$19.4K | 0.02% | 287 |
|